Alnylam Pharmaceuticals
ALNY
ALNY
257 hedge funds and large institutions have $5.26B invested in Alnylam Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 93 increasing their positions, 89 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
32% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 53
33% less capital invested
Capital invested by funds: $7.86B → $5.26B (-$2.6B)
Holders
257
Holding in Top 10
8
Calls
$59.2M
Puts
$43.1M
Top Buyers
| 1 | +$57.1M | |
| 2 | +$42.5M | |
| 3 | +$22.2M | |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$20.3M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$20.1M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$38.5M | |
| 3 | -$31.4M | |
| 4 |
CCI
Columbus Circle Investors
|
-$20.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16M |